| |
| |
|
| Insider
Information: |
Yancopoulos George |
| Relationship: |
Bd. Co-Chair, Presiden... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
786,383 |
|
|
Indirect Shares
|
362,461 |
|
|
| Direct
Value |
$788,702,830 |
|
|
|
Indirect Value
|
$363,530,260 |
|
|
| Total
Shares |
1,148,844 |
|
|
| Total
Value |
$1,152,233,090 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regeneron Pharmaceuticals Inc |
REGN |
Bd. Co-Chair, Presiden... |
2024-05-16 |
786,383 |
2024-05-16 |
362,461 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
145 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
EVP, CSO, & Pres Regn Res Labs |
• • – |
2003-12-15 |
4 |
A |
$0.00 |
$0 |
D/D |
10,277 |
64,817 |
|
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP, CSO, & Pres Regn Res Labs |
• • – |
2007-12-17 |
4 |
A |
$0.00 |
$0 |
D/D |
500,000 |
563,094 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP CSO & Pres Regn Res Labs |
• • – |
2010-12-14 |
4/A |
A |
$0.00 |
$0 |
D/D |
250,000 |
870,375 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP CSO Pres REGN Res Lab |
• • – |
2012-06-27 |
4 |
A |
$0.00 |
$0 |
D/D |
500,000 |
1,333,041 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP, Chief Sci. Off. and Pres, |
• • – |
2003-07-09 |
4 |
AS |
$16.31 |
$21,839 |
D/D |
(1,339) |
54,540 |
|
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP, CSO, & Pres Regn Res Labs |
• • – |
2004-01-09 |
4 |
AS |
$15.18 |
$20,533 |
D/D |
(1,339) |
63,478 |
|
- |
|
| REGN |
Regeneron Pharmaceuticals... |
officerTitle |
• • – |
2005-12-27 |
4 |
AS |
$14.80 |
$81,841 |
D/D |
(5,500) |
64,450 |
|
- |
|
| REGN |
Regeneron Pharmaceuticals... |
officerTitle |
• • – |
2006-01-09 |
4 |
AS |
$16.87 |
$15,600 |
D/D |
(900) |
65,926 |
|
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP, CSO, & Pres Regn Res Labs |
• • – |
2007-01-03 |
4 |
AS |
$20.00 |
$382,870 |
D/D |
(19,123) |
66,686 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP, CSO, & Pres Regn Res Labs |
• • – |
2007-01-04 |
4 |
AS |
$20.00 |
$77,640 |
D/D |
(3,882) |
66,686 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP, CSO, & Pres Regn Res Labs |
• • – |
2007-04-09 |
4 |
AS |
$23.80 |
$227,633 |
D/D |
(9,556) |
67,096 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP, CSO, & Pres Regn Res Labs |
• • – |
2007-04-16 |
4 |
AS |
$24.97 |
$9,991 |
D/D |
(400) |
67,096 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP, CSO, & Pres Regn Res Labs |
• • – |
2007-04-16 |
4 |
AS |
$24.40 |
$758,006 |
D/D |
(30,883) |
67,496 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP, CSO, & Pres Regn Res Labs |
• • – |
2008-12-16 |
4 |
AS |
$16.40 |
$442,652 |
D/D |
(26,991) |
563,094 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP CSO President Regeneron Re |
• • – |
2011-12-01 |
4 |
AS |
$58.86 |
$1,645,591 |
D/D |
(27,713) |
899,270 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP, CSO & Pres, REGN Res Labs |
• • – |
2012-01-05 |
4 |
AS |
$58.00 |
$1,607,354 |
D/D |
(27,713) |
833,041 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP CSO President Regeneron Re |
• • – |
2012-03-26 |
4 |
AS |
$120.21 |
$3,985,850 |
D/D |
(33,150) |
866,206 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP CSO President Regeneron Re |
• • – |
2012-05-01 |
4 |
AS |
$133.95 |
$4,471,669 |
D/D |
(33,165) |
833,041 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2014-02-12 |
4 |
AS |
$317.82 |
$28,504,985 |
D/D |
(88,987) |
1,068,343 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2015-11-02 |
4 |
AS |
$561.75 |
$24,778,125 |
D/D |
(43,348) |
543,348 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2015-12-02 |
4 |
AS |
$542.72 |
$23,799,539 |
D/D |
(43,348) |
500,000 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2020-02-24 |
4 |
AS |
$420.17 |
$49,631,741 |
D/D |
(118,123) |
517,799 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2020-03-10 |
4 |
AS |
$461.79 |
$55,428,041 |
D/D |
(117,815) |
517,799 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2021-06-21 |
4 |
AS |
$532.89 |
$43,112,141 |
I/I |
(80,000) |
2,108 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2021-08-05 |
4 |
AS |
$600.06 |
$30,003,000 |
D/D |
(50,000) |
937,483 |
0 |
% |
|
145 Records found
|
|
Page 1 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
